Entities / Company
Tilray.
pharmaceutical and cannabis company
- Reports this week
- 2
- Active events
- 4
- Connections
- 76
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Both InterCure and Tilray are small-cap healthcare providers.Some support1 report
-
Potential agreement for Carlsberg beer products in the U.S.Some support1 report
-
Democrats winning seats could boost cannabis stocks, causing market surges when reform is discussed.Some support1 report
-
Tilray acquired BrewDog for beverage expansion and is being compared to Nvidia's growth potential.Well supported9 reports2 developments inside
Earlier this month
-
Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.Well supported7 reports1 development inside
-
Tilray seeks scale comparable to market leaders in the industry, such as Coca-Cola.Some support4 reports
-
MarketBeat aggregated consensus rating data for Tilray, which is the subject of a target price reduction and rating change involving Td Securities and TD Cowen.Some support1 report
One to three months ago
-
Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.Some support2 reports
-
Tilray launched new medical cannabis strains in Germany, aiming to improve access in Europe's largest market.Well supported7 reports
-
Td Securities and TD Cowen provided new analyst ratings and price targets for Tilray Brands.Some support1 report
-
Nvidia and Tilray are involved in a comparison of company sizes against a former chipmaker.Some support2 reports1 development inside
-
Tilray Inc was listed on the Nasdaq exchange, and BrewDog was included in Tilray's business platform.Some support2 reports
-
Benzinga reported on the stock price action of Tilray.Some support1 report
-
Breckenridge Distillery is confirmed to be a subsidiary of Tilray Brands, Inc.Well supported5 reports
-
Tilray is the leading player in the Canadian cannabis market.Well supported4 reports1 development inside
-
Tilray bought parts of BrewDog's UK and Ireland business, successfully leading the ownership transition.Some support3 reports
-
Executive order shifts cannabis classification from Schedule I to Schedule III.Well supported6 reports2 developments inside
Gone quiet
No new reports in 90+ days-
Tilray completed an acquisition that established an integrated medical cannabis framework.Some support3 reports
-
Tilray launched Hi*Ball in the UK market.Some support2 reports
-
Tilray launched cannabis products across Canada from its Toronto base.Some support3 reports
-
Tilray, a company based in Canada, has begun exporting medical-grade cannabis products to markets in Europe.Well supported6 reports5 developments inside
-
Tilray's clinic participated in an Aldershot event while expanding regulated access across the UK.Some support3 reports
-
Tilray plans to expand its brand presence into Africa, Europe, and the Middle East, utilizing e-commerce platforms and recent acquisitions.Some support1 report
-
Tilray is expanding its global operational footprint, confirming presence in Europe, Latin America, the United States, Canada, Australia, and Europe.Well supported5 reports4 developments inside
-
BrewDog, a brand under the Tilray corporate umbrella, is running a major sales campaign across the U.K.Some support2 reports
-
Tilray and Integral Ad Science are mentioned as high-performing and small-cap stocks.Speculative1 report
-
Tilray published pioneering research on cannabinoid pharmacokinetics.Speculative1 report
-
Tilray announced the expansion of its investment portfolios within the US market.Some support1 report1 development inside
-
Tilray brands are rolling out events across the U.S.Speculative1 report
-
Tilray has established operational presence in the United States, Canada, Australia, and Europe.Speculative1 report
-
DEA confirms Terrance Cole as Administrator, advancing cannabis rescheduling efforts relevant to Tilray.Some support1 report
-
Hopes for the U.S. marijuana market opening up led investors to pivot toward cheaper stocks in July 2025.Some support1 report
-
US cannabis rescheduling is expected to favor Tilray.Some support2 reports1 development inside
-
Tilray benefits from the easing of federal research restrictions on cannabis.Some support1 report
-
Alliance Global Partners cut price target on Tilray stock on July 23, 2025, citing softness in international sales.Some support1 report
-
Tilray and Curaleaf are reported to dominate the cannabis pharmaceuticals market.Some support2 reports
-
Tilray acquired beer brands, including Anheuser-Busch, solidifying its presence as a brewer in the US on August 1, 2025.Some support1 report
-
Tilray launched new protein crackers at Whole Foods Market, while the possibility of Trump's administration reclassifying marijuana was also discussed.Some support2 reports
-
Tilray leads the European medical cannabis market and aims to broaden access through a new partnership involving Italy, Portugal, and Poland.Some support3 reports
-
Tilray is facing operational challenges due to delayed export permits and regulatory hurdles in Europe, specifically in Portugal and Spain, causing underperformance.Some support2 reports
-
Tilray and SunOpta formed a strategic partnership to expand medical cannabis operations in Italy.Some support2 reports
-
Tilray, a cannabis company, engages in research and distribution, using CouchDB technologies, amid a market selloff triggered by tariffs.Some support1 report
-
Jefferies analysts raised price target on Tilray stock on August 28, 2025.Some support1 report
-
Tariff uncertainty caused stock declines for several companies, including Monster Beverage, Plug Power, GoPro, Chegg, SolarEdge, and Tilray, on September 3, 2025.Some support1 report
-
A partnership between Auntie Anne's and Tilray has been established to promote joint sales and brand visibility.Some support1 report
-
Tilray launched products through licensed retailers in Canada on May 28, 2026.Some support2 reports1 development inside
No events began in the chosen period. Widen it, or reset.
Around Tilray this week
News at the entities that move Tilray most-
BrewDog StructuralCreditor claims are affecting BrewDog's financial standing.Moves Tilray
-
TD Cowen Mentioned togetherAnalyst downgraded Ag Growth International Inc. due to debt management risks.Moves Tilray
-
Donald Trump OperationalThe Trump administration utilized the Department of Health & Human Services for an AI tool.Moves Tilray
-
Italy StructuralFast food chains are rapidly expanding across Italy.Moves Tilray
-
Amazon StructuralNvidia is expanding its platform deployment across major cloud providers, including Google Cloud and Microsoft Azure.Moves Tilray
-
Portugal OperationalDavid Guetta, Jorja Smith, and Maisie Peters are performing at the Millennium Dome venue in London, following shows in Portugal and Belgium.Moves Tilray
Connections
The 28 strongest of 76, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
BrewDog Structural
Tilray acquired BrewDog and operates it as a subsidiary brand integrated into its corporate beverage platform.
-
Breckenridge Structural
Tilray Brands, Inc. owns Breckenridge Distillery as a subsidiary.
-
Anheuser-Busch Structural
Tilray acquired Anheuser-Busch and its beer brands, establishing a structural ownership relationship.
-
Nasdaq Structural
Tilray is formally listed and trades on the Nasdaq stock exchange.
-
Italy Structural
Tilray established a formal presence in Italy through regulatory authorization and strategic partnerships to distribute medical cannabis.
-
TD Cowen Mentioned together
TD Cowen provides financial analysis, including rating changes and price targets, for Tilray.
-
Donald Trump Operational
Tilray's business prospects are influenced by Donald Trump's proposals regarding cannabis reclassification and federal policy.
-
Europe Operational
Tilray actively conducts business, including medical cannabis exports and sales, within the diverse and regulated markets of Europe.
Show all 28 connections
-
CanniMed Operational
Both companies are described as competitors in the cannabis-based therapies market facing shared market challenges.
-
Spain Structural
Spain's regulatory challenges directly impact Tilray's sales and operational activities.
-
AlixPartners Transactional
AlixPartners was responsible for overseeing a specific acquisition deal involving Tilray.
-
Amazon Structural
Tilray leverages Amazon as a sales platform for its Hi*Ball energy drinks.
-
Portugal Operational
Tilray operates in Portugal, and its sales and market activities are directly influenced by Portuguese regulatory challenges.
-
MarketBeat Mentioned together
MarketBeat provides financial ratings and consensus target prices for Tilray.
-
Democrats Shared context
The company's success is forecast to be boosted by the potential electoral outcomes of the Democratic bloc.
-
InterCure Mentioned together
Both companies are categorized as small-cap healthcare providers.
-
Latin America Shared context
Tilray operates within the geographic and market context of Latin America.
-
Nvidia Mentioned together
The companies are co-mentioned in financial articles as high-performing investment targets and growth stocks.
-
Coca-Cola Operational
Tilray is actively competing with Coca-Cola, benchmarking its scale against market leaders.
-
Aldershot Shared context
Tilray operates its clinic and expands medical cannabis access within the Aldershot area.
-
Middle East Shared context
Tilray plans to expand its brand presence into the Middle East market.
-
Td Securities Mentioned together
Td Securities provides buy/sell ratings and target price analysis for Tilray.
-
Republicans Mentioned together
Tilray's stock performance is observed to react positively to discussions of cannabis reform by political entities.
-
Benzinga Mentioned together
Benzinga, a major financial news platform, reports on Tilray's stock price and market activity.
-
FDA Structural
Tilray benefits from products that have successfully navigated the approval and regulatory standards set by the FDA.
-
Africa Shared context
Tilray plans to expand its brand presence into the African market.
-
London Shared context
Tilray participates in the Cannabis Europa event held in London.
-
Poland Shared context
Tilray operates within Poland, leveraging the European medical cannabis market.
History
Events by the month they beganSeptember 2026
5 events- Both InterCure and Tilray are small-cap healthcare providers.
- Potential agreement for Carlsberg beer products in the U.S.
- Democrats winning seats could boost cannabis stocks, causing market surges when reform is discussed.
- Tilray seeks scale comparable to market leaders in the industry, such as Coca-Cola.
- MarketBeat aggregated consensus rating data for Tilray, which is the subject of a target price reduction and rating change involving Td Securities and TD Cowen.
August 2026
1 eventJuly 2026
4 events- Nvidia and Tilray are involved in a comparison of company sizes against a former chipmaker.
- Tilray Inc was listed on the Nasdaq exchange, and BrewDog was included in Tilray's business platform.
- Benzinga reported on the stock price action of Tilray.
- Tilray bought parts of BrewDog's UK and Ireland business, successfully leading the ownership transition.
Show 1 earlier month
June 2026
36 events- Tilray acquired BrewDog for beverage expansion and is being compared to Nvidia's growth potential.
- Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.
- Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.
- Tilray launched new medical cannabis strains in Germany, aiming to improve access in Europe's largest market.
- Breckenridge Distillery is confirmed to be a subsidiary of Tilray Brands, Inc.
- Tilray is the leading player in the Canadian cannabis market.
- Executive order shifts cannabis classification from Schedule I to Schedule III.
- Tilray completed an acquisition that established an integrated medical cannabis framework.
- Tilray launched Hi*Ball in the UK market.
- Tilray launched cannabis products across Canada from its Toronto base.
- Tilray, a company based in Canada, has begun exporting medical-grade cannabis products to markets in Europe.
- Tilray's clinic participated in an Aldershot event while expanding regulated access across the UK.
- Tilray plans to expand its brand presence into Africa, Europe, and the Middle East, utilizing e-commerce platforms and recent acquisitions.
- Tilray is expanding its global operational footprint, confirming presence in Europe, Latin America, the United States, Canada, Australia, and Europe.
- BrewDog, a brand under the Tilray corporate umbrella, is running a major sales campaign across the U.K.
- Tilray and Integral Ad Science are mentioned as high-performing and small-cap stocks.
- Tilray published pioneering research on cannabinoid pharmacokinetics.
- Tilray announced the expansion of its investment portfolios within the US market.
- Tilray brands are rolling out events across the U.S.
- Tilray has established operational presence in the United States, Canada, Australia, and Europe.
- DEA confirms Terrance Cole as Administrator, advancing cannabis rescheduling efforts relevant to Tilray.
- Hopes for the U.S. marijuana market opening up led investors to pivot toward cheaper stocks in July 2025.
- US cannabis rescheduling is expected to favor Tilray.
- Tilray benefits from the easing of federal research restrictions on cannabis.
- Alliance Global Partners cut price target on Tilray stock on July 23, 2025, citing softness in international sales.
- Tilray and Curaleaf are reported to dominate the cannabis pharmaceuticals market.
- Tilray acquired beer brands, including Anheuser-Busch, solidifying its presence as a brewer in the US on August 1, 2025.
- Tilray launched new protein crackers at Whole Foods Market, while the possibility of Trump's administration reclassifying marijuana was also discussed.
- Tilray leads the European medical cannabis market and aims to broaden access through a new partnership involving Italy, Portugal, and Poland.
- Tilray is facing operational challenges due to delayed export permits and regulatory hurdles in Europe, specifically in Portugal and Spain, causing underperformance.
- Tilray and SunOpta formed a strategic partnership to expand medical cannabis operations in Italy.
- Tilray, a cannabis company, engages in research and distribution, using CouchDB technologies, amid a market selloff triggered by tariffs.
- Jefferies analysts raised price target on Tilray stock on August 28, 2025.
- Tariff uncertainty caused stock declines for several companies, including Monster Beverage, Plug Power, GoPro, Chegg, SolarEdge, and Tilray, on September 3, 2025.
- A partnership between Auntie Anne's and Tilray has been established to promote joint sales and brand visibility.
- Tilray launched products through licensed retailers in Canada on May 28, 2026.